# AbbVie net income entity: /record/abbvie.md predicate: net_income page: /record/abbvie/net_income as_of: 2026-11-09 cite: AsOf. "AbbVie quarterly net income: 4,218,000,000 United States dollar", as of 2026-09-30. Claim clm_B8246C4E0E64, https://asof.is/claim/clm_B8246C4E0E64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm. As of November 9, 2026, the latest net income figure on the AsOf record for AbbVie is $4.22 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). AbbVie's latest full-year net income is $4.23 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 12 claims on AbbVie's net income, 1 open and 11 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest net income The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_net_income claim, kept apart from the full-year series. - [AbbVie](/record/abbvie.md) | quarterly_net_income | 4,218,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_B8246C4E0E64](/claim/clm_B8246C4E0E64.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000037/0001551152-26-000037-index.htm ## Latest full-year net income What the record asserts on 2026-11-09. - [AbbVie](/record/abbvie.md) | net_income | 4,226,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [AbbVie](/record/abbvie.md) | net_income | 1,774,000,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_E3B87E01B082](/claim/clm_E3B87E01B082.md) | [clm_C1C38D8E4FB1](/claim/clm_C1C38D8E4FB1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | net_income | 5,144,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_F05A32E90FA3](/claim/clm_F05A32E90FA3.md) | [clm_E3B87E01B082](/claim/clm_E3B87E01B082.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | net_income | 5,953,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_C95C497479DE](/claim/clm_C95C497479DE.md) | [clm_F05A32E90FA3](/claim/clm_F05A32E90FA3.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115217000004/0001551152-17-000004-index.htm - [AbbVie](/record/abbvie.md) | net_income | 5,309,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_E37E3A79E8BD](/claim/clm_E37E3A79E8BD.md) | [clm_C95C497479DE](/claim/clm_C95C497479DE.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115218000014/0001551152-18-000014-index.htm - [AbbVie](/record/abbvie.md) | net_income | 5,687,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_FB8073B6F4C9](/claim/clm_FB8073B6F4C9.md) | [clm_E37E3A79E8BD](/claim/clm_E37E3A79E8BD.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115219000008/0001551152-19-000008-index.htm - [AbbVie](/record/abbvie.md) | net_income | 7,882,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_0EF09B7EC590](/claim/clm_0EF09B7EC590.md) | [clm_FB8073B6F4C9](/claim/clm_FB8073B6F4C9.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115220000007/0001551152-20-000007-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,616,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_37B2CAD3C6F1](/claim/clm_37B2CAD3C6F1.md) | [clm_0EF09B7EC590](/claim/clm_0EF09B7EC590.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115221000008/0001551152-21-000008-index.htm - [AbbVie](/record/abbvie.md) | net_income | 11,542,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_DEF5E95E0C29](/claim/clm_DEF5E95E0C29.md) | [clm_37B2CAD3C6F1](/claim/clm_37B2CAD3C6F1.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115222000007/0001551152-22-000007-index.htm - [AbbVie](/record/abbvie.md) | net_income | 11,836,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_89DC93530D47](/claim/clm_89DC93530D47.md) | [clm_DEF5E95E0C29](/claim/clm_DEF5E95E0C29.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115223000011/0001551152-23-000011-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,863,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_4595D4B200E2](/claim/clm_4595D4B200E2.md) | [clm_89DC93530D47](/claim/clm_89DC93530D47.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000011/0001551152-24-000011-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,278,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md) | [clm_4595D4B200E2](/claim/clm_4595D4B200E2.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115225000020/0001551152-25-000020-index.htm - [AbbVie](/record/abbvie.md) | net_income | 4,226,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md) sources: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000008/0001551152-26-000008-index.htm ## What replaced what - $1.77 billion (2014-12-31 to 2015-12-31, [clm_C1C38D8E4FB1](/claim/clm_C1C38D8E4FB1.md)) was replaced by $5.14 billion from 2015-12-31 ([clm_E3B87E01B082](/claim/clm_E3B87E01B082.md)) - $5.14 billion (2015-12-31 to 2016-12-31, [clm_E3B87E01B082](/claim/clm_E3B87E01B082.md)) was replaced by $5.95 billion from 2016-12-31 ([clm_F05A32E90FA3](/claim/clm_F05A32E90FA3.md)) - $5.95 billion (2016-12-31 to 2017-12-31, [clm_F05A32E90FA3](/claim/clm_F05A32E90FA3.md)) was replaced by $5.31 billion from 2017-12-31 ([clm_C95C497479DE](/claim/clm_C95C497479DE.md)) - $5.31 billion (2017-12-31 to 2018-12-31, [clm_C95C497479DE](/claim/clm_C95C497479DE.md)) was replaced by $5.69 billion from 2018-12-31 ([clm_E37E3A79E8BD](/claim/clm_E37E3A79E8BD.md)) - $5.69 billion (2018-12-31 to 2019-12-31, [clm_E37E3A79E8BD](/claim/clm_E37E3A79E8BD.md)) was replaced by $7.88 billion from 2019-12-31 ([clm_FB8073B6F4C9](/claim/clm_FB8073B6F4C9.md)) - $7.88 billion (2019-12-31 to 2020-12-31, [clm_FB8073B6F4C9](/claim/clm_FB8073B6F4C9.md)) was replaced by $4.62 billion from 2020-12-31 ([clm_0EF09B7EC590](/claim/clm_0EF09B7EC590.md)) - $4.62 billion (2020-12-31 to 2021-12-31, [clm_0EF09B7EC590](/claim/clm_0EF09B7EC590.md)) was replaced by $11.54 billion from 2021-12-31 ([clm_37B2CAD3C6F1](/claim/clm_37B2CAD3C6F1.md)) - $11.54 billion (2021-12-31 to 2022-12-31, [clm_37B2CAD3C6F1](/claim/clm_37B2CAD3C6F1.md)) was replaced by $11.84 billion from 2022-12-31 ([clm_DEF5E95E0C29](/claim/clm_DEF5E95E0C29.md)) - $11.84 billion (2022-12-31 to 2023-12-31, [clm_DEF5E95E0C29](/claim/clm_DEF5E95E0C29.md)) was replaced by $4.86 billion from 2023-12-31 ([clm_89DC93530D47](/claim/clm_89DC93530D47.md)) - $4.86 billion (2023-12-31 to 2024-12-31, [clm_89DC93530D47](/claim/clm_89DC93530D47.md)) was replaced by $4.28 billion from 2024-12-31 ([clm_4595D4B200E2](/claim/clm_4595D4B200E2.md)) - $4.28 billion (2024-12-31 to 2025-12-31, [clm_4595D4B200E2](/claim/clm_4595D4B200E2.md)) was replaced by $4.23 billion from 2025-12-31 ([clm_2A3E6A20A337](/claim/clm_2A3E6A20A337.md)) ## Questions this record answers ### What is AbbVie's current net income? The latest figure on the record is $4.22 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $4.23 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 9, 2026. ### What was AbbVie's net income for the quarter ended September 30, 2026? $4.22 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did AbbVie's net income last change? The latest value on the record is $4.23 billion, dated December 31, 2025; before it the record holds $4.28 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was AbbVie's net income before $4.23 billion? $4.28 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/abbvie/net_income (markdown: /record/abbvie/net_income.md) - Entity twin: /record/abbvie.md ยท timeline: /timelines/abbvie.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.